<DOC>
	<DOCNO>NCT02897427</DOCNO>
	<brief_summary>There 2 part study : pre-screening `` main '' clinical research study . The goal pre-screening part study learn participant antibody human papillomavirus ( HPV ) . Antibodies create immune system may attack foreign cell diseased cell , HPV . The goal main study learn relationship HPV cancer risk men test positive HPV antibody . Researchers want look early method screen certain type cancer . HPV infection lead oropharyngeal , anal , and/or penile cancer . The goal entire study learn screen HPV help doctor learn participant may high risk develop type cancer .</brief_summary>
	<brief_title>HOUSTON - HPV-related Oropharyngeal Uncommon Cancers Screening Trial Of Men</brief_title>
	<detailed_description>Pre-Screening : If participant agrees take part pre-screening part study , follow test procedure Clinical Research Unit Texas Medical Center ( CRU ) : - Participant interview member study staff ask complete questionnaire cancer history , age , sex , race , income , smoke alcohol drinking history , sexual behavior . It take around 15-20 minute complete . - Participant also ask provide oral rinse sample test HPV . Participant swish small amount mouthwash 15 second , gargle another 15 second , spit mouthwash cup . - Blood ( 2 teaspoon ) draw test HPV antibody . Because test use study check HPV antibodies FDA approve , participant tell HPV antibody . Up 90 men test positive HPV antibodies 90 men test negative HPV antibody select take part main study . Participant tell HPV-antibody positive negative . If participant select take part main study , give separate consent form sign explain main study detail , include expect tests/procedures risk . If participant select part main study , study staff contact 1 time year 5 year check health status ask diagnosis cancer HPV-related disease . Participant may contact phone , mail , email . If participant call , last 5 minute . This investigational study . Up 3000 participant may take part pre-screening study . All enrol CRU . Follow-up Cohort : Cancers Caused HPV In Men Screening ( CCHIMES ) : If participant eligible take part study , agree , screen cancer and/or dysplasia ( type pre-cancerous lesion ) . These visit MD Anderson . Participant may refuse take part part screen procedure stop take part study time . Participant 's first visit time sign consent form . Oropharyngeal Cancer Screening : During participant 's first study visit every 6 month 5 year , screen oropharyngeal cancer . At screening : - Participant head neck exam . - Blood ( 6 teaspoon ) draw test participant 's immune system respond infection . - Participant oropharyngeal exam look anything unusual throat . A member research team use narrow band image device look back participant 's throat . A narrow band image device ultra-thin flexible probe video camera end pas participant 's nose shine light back throat . The video display color TV researcher look anything unusual , sign cancer . - Participant 's tonsil back tongue rub cotton swab test HPV . - Participant ultrasound scan throat lymph node neck check cancer and/or dysplasia . To , ultrasound probe place outside neck . Anal Cancer Screening : At participant 's first study visit : - Participant anal pap test test HPV . To perform test , anal sample collect gently swab anal area cotton swab . - Blood ( 6 teaspoon ) draw test participant 's immune system respond infection . - Participant high-resolution anoscopy ( HRA ) . HRA exam anal canal use check anal cancer dysplasia . During exam , liquid solution dilute acetic acid ( normally find vinegar ) flush participant 's anal canal help pre-cancerous area show good exam . Then , small tube camera end ( call colposcope ) insert participant 's anus use take picture possible pre-cancerous area . This exam take 5-10 minute . Participant sedate procedure . Penile Cancer Screening : At participant 's first study visit : - The doctor examine participant 's genital area check anything abnormal . - Urine collect routine test . - Participant 's penis rub cotton-like swab test HPV . If participant abnormal test result screening procedure , refer doctor discus test and/or treatment option , part standard care . Length Study : Participation study participant 's last oropharyngeal cancer screening ( 5 year first study visit ) . This investigational study . Up 3000 men may enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lip Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Male</mesh_term>
	<criteria>1 . Male 2 . Aged 5059 enrollment 3 . US resident 4 . Sign approve informed consent document 1 . Patients previously document squamous cell carcinoma oropharynx , anus , penis ; 2 . Patients receive blood transfusion last 6 month 3 . Other medical psychiatric illness social situation would limit study compliance .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Oropharyngeal cancer</keyword>
	<keyword>Anal cancer</keyword>
	<keyword>Penile cancer</keyword>
	<keyword>Human papillomavirus</keyword>
	<keyword>HPV</keyword>
	<keyword>HPV 16 E antigen</keyword>
	<keyword>Oropharyngeal cancer screen</keyword>
	<keyword>Dysplasia</keyword>
	<keyword>Ultrasound scan throat lymph node neck</keyword>
	<keyword>Anal cancer screen</keyword>
	<keyword>Anal pap test</keyword>
	<keyword>High-resolution anoscopy</keyword>
	<keyword>HRA</keyword>
	<keyword>Penile cancer screen</keyword>
</DOC>